California AB1682 requires health insurance coverage for scalp cooling to reduce chemotherapy-induced hair loss.
California AB1682 mandates that large group health insurance policies and health care service plans, issued or renewed after January 1, 2027, must cover scalp cooling. This involves using FDA-cleared medical devices applied to the scalp during chemotherapy to mitigate hair loss. Small group policies and plans must offer this coverage. Medi-Cal managed care plans are exempt, governed by separate regulations. Coverage can include copayments, coinsurance, or deductibles, but these must be no less favorable than those for oncology supportive care services.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.